{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T12:58:19Z","timestamp":1794056299950,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011400","name":"State Key Laboratory of Analytical Chemistry for Life Science","doi-asserted-by":"publisher","award":["5431ZZXM2208"],"award-info":[{"award-number":["5431ZZXM2208"]}],"id":[{"id":"10.13039\/501100011400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011244","name":"Nanjing University State Key Laboratory of Analytical Chemistry for Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011244","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2021707"],"award-info":[{"award-number":["BE2021707"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jconrel.2025.113862","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:09:53Z","timestamp":1747422593000},"page":"113862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy"],"prefix":"10.1016","volume":"383","author":[{"given":"Shudan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113862_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.797292","article-title":"Idiopathic pulmonary fibrosis: an update on pathogenesis","volume":"12","author":"Mei","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113862_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1513\/pats.200601-005TK","article-title":"Classification and natural history of the idiopathic interstitial pneumonias","volume":"3","author":"Kim","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.jconrel.2025.113862_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu. Rev. Pathol.:Mech. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12964-018-0300-8","article-title":"M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis","volume":"16","author":"Hou","year":"2018","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113862_bb0025","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1111\/febs.15669","article-title":"Alveolar epithelial cell-derived sonic hedgehog promotes pulmonary fibrosis through OPN-dependent alternative macrophage activation","volume":"288","author":"Hou","year":"2021","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0030","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/s12967-023-04279-0","article-title":"Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis","volume":"21","author":"Ji","year":"2023","journal-title":"J. Transl. Med."},{"issue":"6894","key":"10.1016\/j.jconrel.2025.113862_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"issue":"7006","key":"10.1016\/j.jconrel.2025.113862_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/nature02872","article-title":"Revealing the world of RNA interference","volume":"431","author":"Mello","year":"2004","journal-title":"Nature"},{"issue":"6893","key":"10.1016\/j.jconrel.2025.113862_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/418038a","article-title":"RNA interference in adult mice","volume":"418","author":"McCaffrey","year":"2002","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jconrel.2025.113862_bb0050","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid nanoparticle technology for clinical translation of siRNA therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113862_bb0055","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/ar300048p","article-title":"Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges","volume":"45","author":"Gomes-da-Silva","year":"2012","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMp1614154","article-title":"Oligonucleotide therapeutics\u2014a new class of cholesterol-lowering drugs","volume":"376","author":"Khvorova","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transd. Target. Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113862_bb0070","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2007.06.015","article-title":"Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome","volume":"47","author":"Watanabe","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113862_bb0075","article-title":"Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR\u2013Cas gene editing","volume":"1-11","author":"Zhao","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113862_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7228","key":"10.1016\/j.jconrel.2025.113862_bb0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","article-title":"The promises and pitfalls of RNA-interference-based therapeutics","volume":"457","author":"Castanotto","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113862_bb0090","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1007\/s12274-018-2099-4","article-title":"Design of synthetic materials for intracellular delivery of RNAs: From siRNA-mediated gene silencing to CRISPR\/Cas gene editing","volume":"11","author":"Miller","year":"2018","journal-title":"Nano Res."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113862_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202214935","article-title":"Supramolecular polyphenol\u2010DNA microparticles for in vivo adjuvant and antigen co\u2010delivery and immune stimulation","volume":"62","author":"Qu","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6142","key":"10.1016\/j.jconrel.2025.113862_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.1237265","article-title":"One-step assembly of coordination complexes for versatile film and particle engineering","volume":"341","author":"Ejima","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1360\/SSC-2024-0209","article-title":"Conversion of plant polyphenols into high-value products and multi-disciplinary applications","volume":"55","author":"Wang","year":"2025","journal-title":"Sci. Sin. Chim."},{"key":"10.1016\/j.jconrel.2025.113862_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122961","article-title":"Regulatory T cells engineered with polyphenol-functionalized immunosuppressant nanocomplexes for rebuilding periodontal hard tissue under inflammation-challenged microenvironment","volume":"315","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113862_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202501438","article-title":"Polyphenol\u2010regulated bimetallic artificial metalloproteinases with broad\u2010spectrum RONS scavenging activities for diabetic wound repair","author":"Ou","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113862_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108624","article-title":"Assembly of bioactive nanoparticles via metal\u2013phenolic complexation","volume":"34","author":"Chen","year":"2022","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113862_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202314501","article-title":"Metal\u2010phenolic nanocloaks on cancer cells potentiate STING pathway activation for synergistic cancer immunotherapy","volume":"63","author":"He","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113862_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108200","article-title":"A biologically stable, self-catalytic DNAzyme machine encapsulated by metal-phenolic nanoshells for multiple microRNA imaging","volume":"34","author":"Jin","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113862_bb0135","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1021\/acsnano.7b01530","article-title":"In vivo targeting and positron emission tomography imaging of tumor with intrinsically radioactive metal\u2013organic frameworks nanomaterials","volume":"11","author":"Chen","year":"2017","journal-title":"ACS Nano"},{"issue":"45","key":"10.1016\/j.jconrel.2025.113862_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202312925","article-title":"Direct assembly of metal\u2013phenolic network nanoparticles for biomedical applications","volume":"135","author":"Xu","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.113862_bb0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2020.00113","article-title":"Luteolin attenuates doxorubicin-induced cardiotoxicity through promoting mitochondrial autophagy","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2025.113862_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123405","article-title":"Cyclodextrin MOFs modified dry powder inhalers quadruple bioavailability of luteolin to ameliorate fibrosing interstitial lung disease","volume":"645","author":"Ren","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113862_bb0155","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd.2017.170","article-title":"Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease","volume":"16","author":"Mora","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113862_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/17460441.2017.1281245","article-title":"The importance of translatability in drug discovery","volume":"12","author":"Rezaee","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113862_bb0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd3385","article-title":"Advances in the preclinical testing of cancer therapeutic hypotheses","volume":"10","author":"Caponigro","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113862_bb0170","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113862_bb0175","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrd3845","article-title":"Reducing safety-related drug attrition: the use of in vitro pharmacological profiling","volume":"11","author":"Bowes","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113862_bb0180","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pupt.2011.05.001","article-title":"Exploring lung physiology in health and disease with lung slices","volume":"24","author":"Sanderson","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113862_bb0185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/toxics12090637","article-title":"The fibrotic phenotype of human precision-cut lung slices is maintained after cryopreservation","volume":"12","author":"Marimoutou","year":"2024","journal-title":"Toxics"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113862_bb0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrd2310","article-title":"Interfering with disease: a progress report on siRNA-based therapeutics","volume":"6","author":"de Fougerolles","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113862_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115052","article-title":"A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics","volume":"201","author":"Ranjbar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113862_bb0200","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012034","article-title":"Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosis","volume":"12","author":"Zhang","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","article-title":"Alternatively activated alveolar macrophages in pulmonary fibrosis: mediator production and intracellular signal transduction","volume":"137","author":"Pechkovsky","year":"2010","journal-title":"Clin. Immunol."},{"issue":"15","key":"10.1016\/j.jconrel.2025.113862_bb0210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113862_bb0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0005-2736(99)00013-9","article-title":"C1q Binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence-independent manner","volume":"1418","author":"Bradley","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"19","key":"10.1016\/j.jconrel.2025.113862_bb0225","doi-asserted-by":"crossref","first-page":"10356","DOI":"10.1073\/pnas.94.19.10356","article-title":"The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2-glycoprotein I (and other proteins)","volume":"94","author":"Horkko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113862_bb0230","first-page":"441","article-title":"Antibodies to cholesterol, cholesterol conjugates, and liposomes: implications for atherosclerosis and autoimmunity","volume":"10","author":"Alving","year":"1991","journal-title":"Crit. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113862_bb0235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/acs.biomac.0c01463","article-title":"Microemulsion-assisted templating of metal-stabilized poly(ethylene glycol) nanoparticles","volume":"22","author":"Science Lin","year":"2021","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113862_bb0240","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00864-2021","article-title":"Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis","volume":"59","author":"Song","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113862_bb0245","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.7b05465","article-title":"Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages","volume":"11","author":"Qian","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113862_bb0250","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.actbio.2023.12.006","article-title":"Spatial targeting of fibrosis-promoting macrophages with nanoscale metal-organic frameworks for idiopathic pulmonary fibrosis therapy","volume":"174","author":"Hou","year":"2024","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113862_bb0255","doi-asserted-by":"crossref","DOI":"10.1097\/MAJ.0b013e31821aa000","article-title":"Progress toward improving animal models for idiopathic pulmonary fibrosis","volume":"341","author":"Degryse","year":"2011","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113862_bb0260","article-title":"An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices","volume":"312","author":"Alsafadi","year":"2017","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113862_bb0265","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/molecules26041123","article-title":"Identification of key candidate genes involved in the progression of idiopathic pulmonary fibrosis","volume":"26","author":"Cui","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113862_bb0270","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2017-0096ST","article-title":"An official American Thoracic Society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis","volume":"56","author":"Jenkins","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.113862_bb0275","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1440-1827.1995.tb03503.x","article-title":"Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats","volume":"45","author":"Usuki","year":"1995","journal-title":"Pathol. Int."},{"issue":"22","key":"10.1016\/j.jconrel.2025.113862_bb0280","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113862_bb0285","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone clinical study group in Japan. Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2025.113862_bb0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rmed.2017.07.062","article-title":"Therapeutic targets in idiopathic pulmonary fibrosis","volume":"131","author":"Kolb","year":"2017","journal-title":"Respir. Med."},{"issue":"146","key":"10.1016\/j.jconrel.2025.113862_bb0295","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"40","key":"10.1016\/j.jconrel.2025.113862_bb0300","doi-asserted-by":"crossref","first-page":"15919","DOI":"10.1073\/pnas.1312197110","article-title":"Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival","volume":"110","author":"Cieslewicz","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.113862_bb0305","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jep.2018.05.019","article-title":"Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies","volume":"225","author":"Aziz","year":"2018","journal-title":"J. Ethnopharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:16:43Z","timestamp":1752571003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925004821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":61,"alternative-id":["S0168365925004821"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113862","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113862"}}